Evidence map›Paper›PMID 41356759›Full record

ReviewWorld journal of radiology2025

Advancements and challenges of ultrasound imaging in the management of thyroid-associated ophthalmopathy.

Ju-Feng Shi, Wei-Yi Zhou, Hong-Xi Zhang, Ya Shen, Hang Zhang, Tuo Li

Abstract readReview
In one paragraph

Review in World journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ju-Feng ShiDepartment of Endocrinology, Shanghai Changzheng Hospital, Shanghai 200433, China.
Wei-Yi ZhouDepartment of Endocrinology, Shanghai Changzheng Hospital, Shanghai 200433, China.
Hong-Xi ZhangDepartment of Endocrinology, Shanghai Changzheng Hospital, Shanghai 200433, China.
Ya ShenDepartment of Ophthalmology, Shanghai Changzheng Hospital, Shanghai 200433, China.
Hang ZhangDepartment of Ultrasound Medicine, Shanghai Changzheng Hospital, Shanghai 200433, China.
Tuo LiDepartment of Endocrinology, Shanghai Changzheng Hospital, Shanghai 200433, China. dr.lituo@smmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid-associated ophthalmopathy (TAO), an autoimmune disorder closely associated with thyroid dysfunction, requires timely diagnosis and ongoing accurate evaluation to improve patient outcomes. With the global incidence of TAO increasing and significantly affecting the quality of life of patients, there is an urgent need for effective diagnostic tools. As a noninvasive imaging technique, ultrasound plays a pivotal role in diagnosing and managing TAO, particularly in the early detection of and monitoring of disease progression. Despite its advantages, ultrasound faces challenges such as limited resolution for deep orbital structures and a lack of standardized protocols, which can lead to diagnostic inaccuracies. This paper reviews the current status of ultrasound applications in TAO, including diagnostic utility, recent technological advances, and key challenges. It proposes strategies for future research and improvement, emphasizing analysis of ultrasound imaging data to develop biomarker stratification models. We propose an integrated multimodal framework that combines ultrasound elastography with deep learning to improve diagnostic precision.

Indexed as

DiagnosticsImagingOphthalmopathyThyroidUltrasound imaging

Identifiers

PMID41356759
PMCPMC12679182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.